1
|
Kichatova VS, Potemkin IA, Asadi Mobarkhan FA, Rumyantseva TD, Semenov SI, Kyuregyan KK, Mikhailov MI. Detection of antibodies to the hepatitis E virus in domestic reindeer ( Rangifer tarandus) in the Republic of Sakha (Yakutia). Vopr Virusol 2023; 68:549-556. [PMID: 38156570 DOI: 10.36233/0507-4088-206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2023] [Indexed: 12/30/2023]
Abstract
INTRODUCTION Although domestic pigs and wild boars are the main reservoir of zoonotic hepatitis E virus (HEV) genotypes in temperate countries, the presence of antibodies to HEV (anti-HEV) in the indigenous population of circumpolar territories, i.e. outside the habitat of wild and domestic pigs, indicates the presence of an alternative reservoir of the virus. Reindeer (Rangifer tarandus) may be a potential reservoir for HEV in the polar regions. The purpose of the study was to determine the prevalence of anti-HEV among domestic reindeer in the Republic of Sakha (Yakutia). MATERIALS AND METHODS Sera from 497 domestic reindeer from the Oymyakon (n = 425) and Ust-Yansky districts (n = 72) of the Republic of Sakha (Yakutia) were tested for anti-HEV. A commercial ELISA kit DS-ELISA-ANTI-HEV-G (Diagnostic Systems-Stolitsa LLC, Russia) was used for detection of anti-HEV IgG, but a rabbit polyclonal antibody against deer IgG labeled with horseradish peroxidase (KPL, USA) at a dilution of 1 : 100 in phosphate-buffered saline were used instead of the human specific conjugate from the kit. RESULTS The average detection rate of anti-HEV in reindeer sera was 15.5% (95% CI: 12.6-19.0%). The detection rate of anti-HEV significantly increased with age, from 3.5% (95% CI: 1.1-9.0%) in calves aged 3-6 months to 25.0% (95% CI: 1.6 -36.5%) in deer aged 2-4 years (p < 0.0001). From this age group, anti-HEV detection rates reached a plateau, not differing significantly between older age groups (p > 0.05). The average anti-HEV detection rate among reindeer 2 years of age and older was 19.0% (95% CI: 15.3-23.4%). There were no statistically significant differences in the frequency of anti-HEV detection between female and male reindeer, both among adult animals and among calves. CONCLUSION The observed anti-HEV detection rates among domestic reindeer in the Republic of Sakha (Yakutia) indicate that infection caused by HEV or an antigenically similar virus is common in these animals. The dynamics of antibody accumulation in the reindeer population indicates that infection apparently occurs during the first two years of life.
Collapse
Affiliation(s)
- V S Kichatova
- Central Research Institute of Epidemiology
- Mechnikov Research Institute of Vaccines and Sera
- Russian Medical Academy of Continuing Professional Education
| | - I A Potemkin
- Central Research Institute of Epidemiology
- Mechnikov Research Institute of Vaccines and Sera
- Russian Medical Academy of Continuing Professional Education
| | - F A Asadi Mobarkhan
- Central Research Institute of Epidemiology
- Mechnikov Research Institute of Vaccines and Sera
| | | | - S I Semenov
- North-Eastern Federal University named after. M.K. Ammosov
| | - K K Kyuregyan
- Central Research Institute of Epidemiology
- Mechnikov Research Institute of Vaccines and Sera
| | - M I Mikhailov
- Central Research Institute of Epidemiology
- Mechnikov Research Institute of Vaccines and Sera
| |
Collapse
|
2
|
Dogadov DI, Kyuregyan KK, Alexandra GM, Minosyan AA, Kochkonyan AA, Karlsen AA, Vyshemirsky OI, Karal-Ogly DD, Mikhailov MI. Markers of antroponotic viral infections in vervet monkeys arrived from their natural habitat (Tanzania). Vopr Virusol 2023; 68:394-403. [PMID: 38156576 DOI: 10.36233/0507-4088-188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Indexed: 12/30/2023]
Abstract
INTRODUCTION Various human viruses have been identified in wild monkeys and in captive primates. Cases of transmission of viruses from wild monkeys to humans and vice versa are known. The aim of this study was to identify markers of anthroponotic viral infections in vervet monkeys (Chlorocebus pygerythrus) arrived from their natural habitat (Tanzania). MATERIALS AND METHODS Fecal samples (n = 56) and blood serum samples (n = 75) obtained from 75 animals, respectively, on days 10 and 23 after admission to the primate center, were tested for the markers of anthroponotic viral infections (Ebola virus, Marburg virus, lymphocytic choriomeningitis, hepatitis C virus, herpes simplex virus (HSV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), parainfluenza types 1 and 3, intestinal adenoviruses, rotaviruses) by enzyme immunoassay (ELISA) and polymerase chain reaction (PCR). RESULTS AND DISCUSSION Among the examined animals, markers of 6 out of 11 tested viral infections were identified. Detection rates of IgG antibodies to HSV-1,2 (15.9%) and CMV (15.9%) were two times as low as IgG antibodies to EBV (31.8%). Among the markers of respiratory viral infections, IgG antibodies to parainfluenza virus type 1 were found (6.8%). 14.3% of the animals had rotavirus antigen, and 94% had simian adenovirus DNA. Markers of hemorrhagic fevers Ebola, Marburg, LCM, hepatitis C, and type 3 parainfluenza were not detected. CONCLUSION When importing monkeys from different regions of the world, an expanded screening for viral infections is needed considering the epidemiological situation both in the country of importation and in the country of destination.
Collapse
Affiliation(s)
- D I Dogadov
- Research Institute of Medical Primatology of the Ministry of Education and Science of Russia
| | - K K Kyuregyan
- Central Research Institute of Epidemiology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
- I.I. Mechnikov Research Institute of Vaccines and Sera
| | - G M Alexandra
- Research Institute of Medical Primatology of the Ministry of Education and Science of Russia
| | - A A Minosyan
- Research Institute of Medical Primatology of the Ministry of Education and Science of Russia
| | - A A Kochkonyan
- Research Institute of Medical Primatology of the Ministry of Education and Science of Russia
| | - A A Karlsen
- Central Research Institute of Epidemiology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
- I.I. Mechnikov Research Institute of Vaccines and Sera
| | - O I Vyshemirsky
- Research Institute of Medical Primatology of the Ministry of Education and Science of Russia
| | - D D Karal-Ogly
- Research Institute of Medical Primatology of the Ministry of Education and Science of Russia
| | - M I Mikhailov
- Central Research Institute of Epidemiology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
- I.I. Mechnikov Research Institute of Vaccines and Sera
| |
Collapse
|
3
|
Dogadov DI, Kyuregyan KK, Mikhailov MI. [Enteral viral hepatitis in monkeys]. Vopr Virusol 2022; 67:173-184. [PMID: 35831960 DOI: 10.36233/0507-4088-110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Accepted: 07/13/2022] [Indexed: 06/15/2023]
Abstract
Within the last decade, a large number of viruses genetically related to human hepatitis viruses have been identified in different animal species, including monkeys. Numerous viruses related to human hepatitis A virus (HAV, Picornaviridae: Hepatovirus: Hepatovirus A) were detected in various mammalian species in 2015-2018, predominantly in bats and rodents, but also in shrews, seals and marsupials. Zoonotic hepatitis E virus (HEV, Hepeviridae: Orthohepevirus: Orthohepevirus A) genotypes have been found in wild boars, deer, camels, and rabbits, as well as in non human primates. In addition, viruses that are genetically close to HEV have been described in bats, ferrets, rodents, birds, and fish. Nevertheless, monkeys remain important laboratory animals in HAV and HEV research. The study of spontaneous and experimental infection in these animals is an invaluable source of information about the biology and pathogenesis of these viruses and continues to be an indispensable tool for vaccine and drug testing. The purpose of this literature review was to summarize and analyze published data on the circulation of HAV and HEV among wild and captive primates, as well as the results of experimental studies of HAV and HEV infections in monkeys.
Collapse
Affiliation(s)
- D I Dogadov
- FSBRI «Research Institute of Medical Primatology» of the Ministry of Education and Science of Russia
| | - K K Kyuregyan
- FSBRI «Research Institute of Medical Primatology» of the Ministry of Education and Science of Russia; FSBRI «I.I. Mechnikov Research Institute of Vaccines and Sera»
| | - M I Mikhailov
- FSBRI «I.I. Mechnikov Research Institute of Vaccines and Sera»; FSBEI FPE «Russian Medical Academy of Continuous Professional Education» of the Ministry of Health of Russia
| |
Collapse
|
4
|
Korzaya LI, Dogadov DI, Goncharenko AM, Karlsen AA, Kyuregyan KK, Mikhailov MI. [Prevalence of laboratory markers of human respiratory viruses in monkeys of Adler primate center]. Vopr Virusol 2022; 66:425-433. [PMID: 35019249 DOI: 10.36233/0507-4088-77] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2022] [Accepted: 01/08/2022] [Indexed: 11/05/2022]
Abstract
INTRODUCTION The relevance of studying the circulation of human respiratory viruses among laboratory primates is associated with the need to test vaccines and antiviral drugs against these infections on monkeys.The aim of this work was to study the prevalence of serological and molecular markers of human respiratory viral infections in laboratory primates born at the Adler Primate Center and in imported monkeys. MATERIAL AND METHODS Blood serum samples (n = 1971) and lung autopsy material (n = 26) were obtained from different monkey species. These samples were tested for the presence of serological markers of measles, parainfluenza (PI) types 1, 2, 3, influenza A and B, respiratory syncytial (RS) and adenovirus infections using enzyme immunoassay (ELISA). Detection of RS virus, metapneumovirus, PI virus types 1-4, rhinovirus, coronavirus, and adenoviruses B, C, E and bocavirus nucleic acids in this material was performed by reverse transcription polymerase chain reaction (RT-PCR). RESULTS AND DISCUSSION The overall prevalence of antibodies (Abs) among all monkeys was low and amounted 11.3% (95% CI: 9.2-13.7%, n = 811) for measles virus, 8.9% (95% CI: 6.2-12.2%, n = 381) for PI type 3 virus, 2.5% (95% CI: 0.8-5.6%, n = 204) for PI type 1 virus, and 7.7% (95% CI: 3.8-13.7%, n = 130) for adenoviruses. When testing 26 autopsy lung samples from monkeys of different species that died from pneumonia, 2 samples from Anubis baboons (Papio аnubis) were positive for of parainfluenza virus type 3 RNA. CONCLUSION Our data suggest the importance of the strict adherence to the terms of quarantine and mandatory testing of monkey sera for the presence of IgM antibodies to the measles virus that indicate the recent infection. The role of PI virus type 3 in the pathology of the respiratory tract in Anubis baboons has been established.
Collapse
Affiliation(s)
- L I Korzaya
- FSBRI «Research Institute of Medical Primatology» of the Ministry of Higher Education and Science of Russia
| | - D I Dogadov
- FSBRI «Research Institute of Medical Primatology» of the Ministry of Higher Education and Science of Russia
| | - A M Goncharenko
- FSBRI «Research Institute of Medical Primatology» of the Ministry of Higher Education and Science of Russia
| | - A A Karlsen
- FSBEI FPE «Russian Medical Academy of Continuous Professional Education» of the Ministry of Health of Russia; FSBRI «I.I. Mechnikov Research Institute of Vaccines and Sera»
| | - K K Kyuregyan
- FSBEI FPE «Russian Medical Academy of Continuous Professional Education» of the Ministry of Health of Russia; FSBRI «I.I. Mechnikov Research Institute of Vaccines and Sera»
| | - M I Mikhailov
- FSBEI FPE «Russian Medical Academy of Continuous Professional Education» of the Ministry of Health of Russia; FSBRI «I.I. Mechnikov Research Institute of Vaccines and Sera»
| |
Collapse
|
5
|
Isaeva OV, Kyuregyan KK, Mikhailov MI. [Animal delta-like viruses (Kolmioviridae: Deltavirus) and the origin of the human hepatitis D virus (HDV)]. Vopr Virusol 2021; 66:340-345. [PMID: 34738449 DOI: 10.36233/0507-4088-78] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2021] [Accepted: 11/04/2021] [Indexed: 11/05/2022]
Abstract
Hepatitis D (delta, δ) virus (HDV) was discovered more than 40 years ago, but the understanding of its origin and evolution is poor. This is mainly due to the lack, until recently, of data on the existence of any viruses similar to HDV. The discovery in recent years of sequences of new delta-like agents in a wide range of vertebrate (Vertebrata) and invertebrate (Invertebrata) species has facilitated a revision of views on the origin of HDV and contributed to understanding the place of this unique virus among other animals' viral agents. The purpose of this review is to analyze the latest published data on new delta-like agents and their biological characteristics.
Collapse
Affiliation(s)
- O V Isaeva
- FSBSI «I.I. Mechnikov Research Institute of Vaccines and Sera»; FSBEI FPE «Russian Medical Academy of Continuous Professional Education» of the Ministry of Health of Russia
| | - K K Kyuregyan
- FSBSI «I.I. Mechnikov Research Institute of Vaccines and Sera»; FSBEI FPE «Russian Medical Academy of Continuous Professional Education» of the Ministry of Health of Russia
| | - M I Mikhailov
- FSBSI «I.I. Mechnikov Research Institute of Vaccines and Sera»; FSBEI FPE «Russian Medical Academy of Continuous Professional Education» of the Ministry of Health of Russia
| |
Collapse
|
6
|
Dogadov DI, Korzaya LI, Kyuregyan KK, Karlsen AA, Mikhailov MI. [Markers of viral hepatitis E (Hepeviridae, Orthohepevirus, Orthohepevirus A) in the imported Old World monkeys]. Vopr Virusol 2021; 66:182-188. [PMID: 34251155 DOI: 10.36233/0507-4088-34] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2021] [Accepted: 07/09/2021] [Indexed: 06/13/2023]
Abstract
INTRODUCTION Viral hepatitis E is a zooanthroponotic disease that occurs in humans and various animals, including monkeys. It is caused by hepatitis E virus (HEV) (Hepeviridae, Orthohepevirus: Orthohepevirus A), for which 8 genotypes have been described to date. Among them, strains of genotypes 1 and 2 have been isolated from humans, strains of genotypes 3 and 4 from humans and animals, and strains of genotypes 5-8 from animals only. The main threat of the disease is associated with the documented zoonotic transmission of HEV genotypes 3, 4, 7, and 8, to humans through infected meat, blood and milk. Thus, monkeys could be involved in the transmission of HEV.The aim of this work was to study serological and molecular genetic markers of HEV infection in strepsirrhines (Old World monkeys, Cercopithecoidea), imported to the Adler Primate Center from various regions of the world (Tanzania, Vietnam, Mauritius). MATERIAL AND METHODS Fecal (n = 224) and blood serum samples (n = 395) from cynomolgus (Macaca fascicularis) and vervet monkeys (Chlorocebus pygerythrus) were examined by the enzyme-linked immunosorbent assay (ELISA) and reverse transcription polymerase chain reaction (RT-PCR). RESULTS AND DISCUSSION The data obtained show the high detection rate (51.8%) of IgG antibodies to HEV among 5 groups of cynomolgus monkeys imported from Vietnam, with a predominance of highly reactive sera (84%). High detection rate of IgM antibodies in these animals (10.4%) was observed, with the large number of IgM-reactive sera in one particular group of animals (36.8%). The fact of detection of HEV RNA in two groups of cynomolgus monkeys (11.9% and 5.7%) is of particular importance. All HEV sequences of isolated from monkeys belonged to genotype 4. CONCLUSION Our data indicate that monkeys (in particular, cynomolgus monkeys) can serve as a natural reservoir of HEV genotype 4 for humans. This requires an appropriate set of anti-epidemic measures in a number of situations.
Collapse
Affiliation(s)
- D I Dogadov
- FSBRI «Research Institute of Medical Primatology» of the Ministry of Education and Science of Russia
| | - L I Korzaya
- FSBRI «Research Institute of Medical Primatology» of the Ministry of Education and Science of Russia
| | - K K Kyuregyan
- FSBRI «I.I. Mechnikov Research Institute of Vaccines and Sera»; FSBEI FPE «Russian Medical Academy of Continuous Professional Education» of the Ministry of Health of Russia
| | - A A Karlsen
- FSBRI «I.I. Mechnikov Research Institute of Vaccines and Sera»; FSBEI FPE «Russian Medical Academy of Continuous Professional Education» of the Ministry of Health of Russia
| | - M I Mikhailov
- FSBRI «I.I. Mechnikov Research Institute of Vaccines and Sera»; FSBEI FPE «Russian Medical Academy of Continuous Professional Education» of the Ministry of Health of Russia
| |
Collapse
|
7
|
Mikhailov MI, Kyuregyan KK. Contemporary strategy to control viral hepatitis A in the Russian Federation. Zhurnal mikrobiologii, èpidemiologii i immunobiologii 2021. [DOI: 10.36233/0372-9311-103] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
The problem of choosing a strategy to control hepatitis A in the Russian Federation remains relevant for the health care of our country. By strategy we mean a scientifically based program of action that defines the priorities and resources needed to effectively control hepatitis A.The aim of the work is to present a strategy to control hepatitis A in the Russian Federation, taking into account the realities of today. Based on the analysis of Russian and international studies, we present answers to the questions that should be addressed before the choosing a strategy to control hepatitis A in the Russian Federation. The low incidence of hepatitis A creates a false image of the favorable situation with this infection. The rationale is given to include vaccination against hepatitis A in the National Vaccination Schedule in the section of mandatory vaccinations. Routine vaccination of children aged 24 and 36 months will lay the foundation for future protection against this infection. We consider the creating a National Hepatitis A Vaccination Program as an important aim. The implementation of such a program will allow full control of hepatitis A in the Russian Federation.
Collapse
Affiliation(s)
- M. I. Mikhailov
- I. Mechnikov Research Institute for Vaccines and Sera;
Russian Medical Academy of Continuous Professional Education
| | - K. K. Kyuregyan
- I. Mechnikov Research Institute for Vaccines and Sera;
Russian Medical Academy of Continuous Professional Education
| |
Collapse
|
8
|
Isaeva OV, Il'chenko LY, Saryglar AA, Karlsen AA, Kyuregyan KK, Mikhailov MI. [Clinical course and outcomes of chronic viral hepatitis D in patients from Republic of Tuva as endemic region]. Vopr Virusol 2021; 66:74-83. [PMID: 33683068 DOI: 10.36233/0507-4088-29] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2021] [Accepted: 03/07/2021] [Indexed: 11/05/2022]
Abstract
INTRODUCTION Hepatitis D (delta, 5) is caused by an RNA virus (hepatitis D virus, HDV) from genus Deltavirus, and is the most severe and difficult to treat disease among both viral hepatitis and infectious diseases in general. The development of HDV infection in the host organism is possible only in the presence of hepatitis B virus (HBV). Coinfection with HBV and HDV is associated with a more rapid progression of chronic viral hepatitis (CVH) to liver cirrhosis (LC) and an unfavorable outcome in comparison with HBV monoinfection. Data on the influence of clinical, biochemical and virological factors on the infectious process in patients with hepatitis D are limited due to the insufficient amount of research on this theme.The study aimed to determine demographic, clinical, biochemical, and virological factors influencing the course and progression of CVH D in patients followed during 10 years, residing in the territory of the Tuva Republic, one of the endemic regions of the Russian Federation. MATERIAL AND METHODS Changes in clinical and laboratory parameters were analyzed in dynamics in 121 HDV infected patients with a different course of the disease, who were under observation from 2009 to 2019. Three groups of patients were identified: group 1 - 61 patients with disease progression of chronic hepatitis to LC (Child-Pugh class B-C), group 2 - 49 patients with non-progressive chronic hepatitis, and group 3 - 11 patients with slowly progressive LC (class A). Demographic data, the presence of detectable HBV DNA, indicators of the functional state of the liver: alanine aminotransferase (ALT/GPT), aspartate aminotransferase (AST/GOT), alkaline phosphatase (ALP), gamma-glutamyltransferase (GGT), and total bilirubin content were analyzed. The severity of hepatic encephalopathy was assessed by the duration of the numbers connection test (NCT). RESULTS All patients belonged to the same ethnic group (Tuvinians), were infected with HDV genotype 1 and were positive for HDV RNA throughout the entire follow-up period. There were no significant differences in sex ratio and mean age at the time of inclusion in the study between the groups. In group 1, the average number of years from inclusion in the study to the formation of LC was 3.65 ± 2.3 years, years to the lethal outcome: 4.5 ± 3 years. Significantly higher levels of AST/GOT, ALP, GGT, total bilirubin (TB) and NCT grade were found in group 1 compared to group 2. ALT/GPT levels did not differ significantly in these groups. When comparing groups with disease progression and slowly progressive LC (groups 1 and 3), no significant differences were found in any of the clinical and biochemical parameters. ALT/GPT, GGT, TB and NCT values were significantly higher in patients with slowly progressive LC (group 3) compared to group 2. No differences in AST/GOT and ALP levels were found between these groups. Detectable HBV DNA was significantly more frequent in patients with progressive disease and with chronic viral hepatitis than in patients with slowly progressive LC. There were no significant differences in the frequency of HBV DNA detection in patients from groups 1 and 2. CONCLUSION The results obtained on a relatively homogeneous cohort demonstrated that age and gender are not the factors influencing the progression of chronic viral hepatitis D to cirrhosis. The lack of detectable HBV DNA is associated with the slow progression of LC. The revealed differences in clinical and biochemical parameters reflect the degree of functional liver damage in chronic viral hepatitis D and HDV-associated cirrhosis.
Collapse
Affiliation(s)
- O V Isaeva
- FSBSI I.I. Mechnikov Research Institute of Vaccines and Sera; FSBEI FPE Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia
| | - L Yu Il'chenko
- FSBSI I.I. Mechnikov Research Institute of Vaccines and Sera; FSBSI M.P. Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences; FSAEI HE N.I. Pirogov Russian Research Medical University of the Ministry of Health of Russia
| | | | - A A Karlsen
- FSBSI I.I. Mechnikov Research Institute of Vaccines and Sera; FSBEI FPE Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia
| | - K K Kyuregyan
- FSBSI I.I. Mechnikov Research Institute of Vaccines and Sera; FSBEI FPE Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia
| | - M I Mikhailov
- FSBSI I.I. Mechnikov Research Institute of Vaccines and Sera; FSBEI FPE Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia
| |
Collapse
|
9
|
Alatortseva GI, Sidorov AV, Nesterenko LN, Luhverchik LN, Dotsenko VV, Amiantova II, Zhukina MV, Kabargina VY, Milovanova AV, Vorobev DS, Ammur YI, Mikhailov MI, Kyuregyan KK, Malinnikova EY, Zhavoronok SV, Blinov VM, Zverev VV. DEVELOPMENT OF HEPATITIS E 3 GENOTYPE RECOMBINANT PROTEIN CAPSID OF: CLONING, EXPRESSION, PURIFICATION, EVALUATION OF THE ANTIGENIC PROPERTIES. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2019. [DOI: 10.36233/0372-9311-2019-1-10-17] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Aim. The development of the hepatitis E virus (HEV) genotype 3 recombinant capsid protein.Materials and methods. E.coli strains, plasmid vectors, serological and clinical samples, ELISA reagent kits, molecular biological, bioinformatic, biotechnological, biochemical and serological methods.Results. Using viruscontaining material from pigs of Belgorod region (Russian Federation) we made E.coli strains producing recombinant capsid protein, containing C-terminal of viral ORF2 protein fragment fused to E.coli β-galactosidase. Recombinant protein ORF2 had been isolated from the bacterial inclusion bodies and purified by size exclusion chromatography. Antigenic specificity of the recombinant polypeptide was confirmed by ELISA and Western blotting with sera of hepatitis E patients and reference groups (healthy donors, patients with hepatitis A, B, C, infectious mononucleosis, cytomegalovirus infection and HIV-infected patients). Conclusion. HEV genotype 3 ORF2 recombinant antigen had been developed, and the possibility to use it in diagnostic tests had been experimentally shown.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | - Yu. I. Ammur
- Mechnikov Research Institute of Vaccines and Sera
| | - M. I. Mikhailov
- Mechnikov Research Institute of Vaccines and Sera, Russian Medical Academy of Postgraduate Education
| | - K. K. Kyuregyan
- Mechnikov Research Institute of Vaccines and Sera, Russian Medical Academy of Postgraduate Education
| | - E. Yu. Malinnikova
- Mechnikov Research Institute of Vaccines and Sera, Russian Medical Academy of Postgraduate Education
| | | | - V. M. Blinov
- Mechnikov Research Institute of Vaccines and Sera
| | - V. V. Zverev
- Mechnikov Research Institute of Vaccines and Sera, Sechenov First Moscow State Medical University
| |
Collapse
|
10
|
Kyuregyan KK, Potemkin IA, Lopatukhina MA, Popova OE, Isaeva OV, Malinnikova EY, Romanemko VV, Polyakov AD, Mikhailov MI. [The duration of preservation of anamnestic antibodies to hepatitis E virus.]. Klin Lab Diagn 2019; 63:310-314. [PMID: 30689328 DOI: 10.18821/0869-2084-2018-63-5-310-314] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2017] [Accepted: 01/16/2018] [Indexed: 11/17/2022]
Abstract
The purpose of the study was to determine the duration of antibody response against hepatitis E virus (anti-HEV). Veterans of the war in Afghanistan who were in this endemic region in the late 1970s and early 1980s were tested for anti-HEV. On average, 20 years after the end of military service in Afghanistan, the rate of seropositivity was 30.0% (95/317), which was significantly higher compared to positivity rates in males who were at military service in the territory of Russia during the same period (3.9%, 8/208). At an average of 29.5 years after the visit to Afghanistan anti-HEV prevalence in veterans dropped to 20.0% (21/105), but still significantly exceeded the seroprevalence in general population (3.8%). Serum samples from elderly individuals (>60 years) without known risk factors of infection were also tested for anti-HEV IgG and IgM (n = 896). Anti-HEV IgG detection rates in the elderly from two regions of Russia exceeded those observed of primary blood donors (18.0-27.8% vs. 4.5-10.0%, p<0.01). The detection of anti-HEV IgM in individuals above 60 years (2.7-6.9%) indicates a current or recent infection. Thus, anti-HEV IgG can persist several decades after the infection. This might account for the wide anti-HEV prevalence among the elderly. At the same time, a significant proportion of individuals exposed to HEV lose detectable anti-HEV IgG within 20-30 years. The detection of anti-HEV IgM among the elderly indicates the viral circulation in older age groups, suggesting the need for testing for hepatitis E markers in elderly patients with liver diseases.
Collapse
Affiliation(s)
- K K Kyuregyan
- The Federal State Budget Educational Institution of Higher Education "I.I. Mechnikov North-Western State Medical University" of Minzdrav of Russia, 191015, St. Petersburg, Russia.,The Federal State Budget Educational Institution of Additional Professional Education "The Russian Medical Academy of Post-graduate Education" of Minzdrav of Russia, 123995, Moscow, Russia
| | - I A Potemkin
- The Federal State Budget Educational Institution of Higher Education "I.I. Mechnikov North-Western State Medical University" of Minzdrav of Russia, 191015, St. Petersburg, Russia.,The Federal State Budget Educational Institution of Additional Professional Education "The Russian Medical Academy of Post-graduate Education" of Minzdrav of Russia, 123995, Moscow, Russia
| | - M A Lopatukhina
- The Federal State Budget Scientific Institution "The M.P. Chumakov Federal Scientific Center of Research and Development of Immunobiological Preparations" of the Russian Academy of Sciences, 142782, Moscow, Russia
| | - O E Popova
- The Federal State Budget Scientific Institution "The M.P. Chumakov Federal Scientific Center of Research and Development of Immunobiological Preparations" of the Russian Academy of Sciences, 142782, Moscow, Russia
| | - O V Isaeva
- The Federal State Budget Educational Institution of Higher Education "I.I. Mechnikov North-Western State Medical University" of Minzdrav of Russia, 191015, St. Petersburg, Russia.,The Federal State Budget Educational Institution of Additional Professional Education "The Russian Medical Academy of Post-graduate Education" of Minzdrav of Russia, 123995, Moscow, Russia
| | - E Yu Malinnikova
- The Federal State Budget Educational Institution of Higher Education "I.I. Mechnikov North-Western State Medical University" of Minzdrav of Russia, 191015, St. Petersburg, Russia.,The Federal State Budget Educational Institution of Additional Professional Education "The Russian Medical Academy of Post-graduate Education" of Minzdrav of Russia, 123995, Moscow, Russia
| | - V V Romanemko
- The Federal State Budget Health Care Institution "The Sverdlovsk oblast Center of Hygiene and Epidemiology", 620078, Yekaterinburg, Russia
| | - A D Polyakov
- The Department of the Rospotrebnadzor in the Sverdlovsk oblast, 308023, Belgorod, Russia
| | - M I Mikhailov
- The Federal State Budget Educational Institution of Higher Education "I.I. Mechnikov North-Western State Medical University" of Minzdrav of Russia, 191015, St. Petersburg, Russia.,The Federal State Budget Educational Institution of Additional Professional Education "The Russian Medical Academy of Post-graduate Education" of Minzdrav of Russia, 123995, Moscow, Russia
| |
Collapse
|
11
|
Dogadov DI, Korzaya LI, Kyuregyan KK, Karlsen AA, Mikhailov MI, Lapin BA. [Markers of hepatitis A in the monkeys of the Adlers primate center.]. Vopr Virusol 2019; 64:246-249. [PMID: 32167690 DOI: 10.36233/0507-4088-2019-64-5-246-249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2019] [Accepted: 06/17/2019] [Indexed: 06/10/2023]
Abstract
UNLABELLED Hepatitis A is a widespread viral infection. The HAV strains of "human" and "monkey" origin are similar in their morphological and antigenic properties, but differ genotypically. OBJECTIVES The aim of this research was a comparative study of serological and molecular-genetic markers of HAV infection in monkeys born at the Adler Primate Center and in those imported from different countries. MATERIAL AND METHODS Fecal samples (n = 313) and serum (n = 266) from various species of monkey using ELISA and RT-PCR were studied. RESULTS AND DISCUSSION The frequency of anti-HAV-IgG was high (78.9%) in imported animals (vervet monkeys from Tanzania and cynomolgus monkeys from Vietnam) and as well as in various species of monkeys (rhesus monkeys, cynomolgus monkeys, green monkeys and papio hamadryas) of the Center (88.6%). At the same time, in the imported monkeys, the markers of "fresh" HAV infection (IgM-27.2%, Ag-HAV-16.7%, RNA-22.0%) were detected significantly more often (p> 0.05) than in monkeys kept at the Colony (IgM-7.5%, HAV-Ag - 5.2%, RNA - 3.6%). In general, anti-IgG reactivity ranged from 1.064 to 2.073 OD450, anti-IgM ranged from 0.546 to 1.059 OD450. The number of HAV-Ag was 0.496 - 1.995 OD450. RNA HAV only in rhesus monkeys and cynomolgys monkeys born at the Colony, as well as in imported vervet monkeys was detected. CONCLUSIONS The data obtained indicate a wide circulation of HAV among monkeys born in the Adler Primate Center and among the imported animals. Markers of "fresh" HAV infection varied depending on the species of monkeys and their origin.
Collapse
Affiliation(s)
- D I Dogadov
- Scientific Research Institute of Medical Primatology, Sochi, 354376, Russia
| | - L I Korzaya
- Scientific Research Institute of Medical Primatology, Sochi, 354376, Russia
| | - K K Kyuregyan
- Mechnikov Research Institute of Vaccines and Sera, Moscow, 105064, Russia
| | - A A Karlsen
- Mechnikov Research Institute of Vaccines and Sera, Moscow, 105064, Russia
| | - M I Mikhailov
- Mechnikov Research Institute of Vaccines and Sera, Moscow, 105064, Russia
| | - B A Lapin
- Scientific Research Institute of Medical Primatology, Sochi, 354376, Russia
| |
Collapse
|
12
|
Kyuregyan KK, Polyakov AD, Potemkin IA, Karlsen AA, Isaeva OV, Lopatukhina MA, Mullin EV, Slukinova OS, Malinnikova EY, Shibrik EV, Oglezneva EE, Mikhailov MI. [Belgorod region - the territory endemic for hepatitis E.]. Vopr Virusol 2019; 64:274-280. [PMID: 32168441 DOI: 10.36233/0507-4088-2019-64-6-274-280] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2019] [Accepted: 12/24/2019] [Indexed: 12/27/2022]
Abstract
INTRODUCTION Belgorod region is the territory with the highest incidence of hepatitis E in the Russian Federation. OBJECTIVES The aim of the study was to comprehensively characterize the circulation of hepatitis E virus (HEV) in the Belgorod region, including the study of population immunity to the virus, determining the prevalence of infection among the pig population and analysis of the genetic diversity of HEV from patients and animals. MATERIAL AND METHODS Serum samples of a conditionally healthy population (n = 2027) of all age groups were tested for anti-HEV IgG and IgM by ELISA with commercial assays. HEV RNA was determined in fecal samples from pigs aged 2-4 months (n = 526), in sewage samples from pig farms (n = 10), as well as in stool samples from patients with hepatitis E (n = 6) using reverse transcription polymerase chain reaction (RT-PCR). Phylogenetic analysis was performed for an amplified 300 nt fragment corresponding to HEV open reading frame 2. RESULTS AND DISCUSSION The prevalence of anti-HEV IgG in general population averaged 16.4% (95% CI: 14.8-18.1; 332/2027). The proportion of individuals who had both anti-HEV IgM and IgG averaged 2.8% (95% CI: 2.2-3.6; 57/2027). The incidence rate of anti-HEV IgG increased with age, from 2.8% (95% CI: 1.3-5.8) in children aged 1-14 years to 40.1% (95% CI: 34.9-45.6) in people 70 years or older. The detection rate of HEV RNA in pigs was 20% (95% CI: 16.8-23.6; 105/526). HEV RNA was detected in 2 out of 10 sewage samples. The HEV sequences isolated from patients with hepatitis E, pigs, and sewage samples in Belgorod region belonged to the HEV genotype 3, had a 95-100% homology, and formed common clusters on a phylogenetic tree. CONCLUSIONS The high prevalence of HEV in pigs population has led to the formation of an endemic territory in the Belgorod region, which is the center of pig breeding. Measures aimed at reducing the circulation of HEV among pig population and decontamination of sewage from pig farms are necessary to control HEV infection.
Collapse
Affiliation(s)
- K K Kyuregyan
- Mechnikov Research Institute for Vaccines and Sera, Moscow, 105064, Russia.,Russian Medical Academy of Continuous Professional Education, Moscow, 125993, Russia
| | - A D Polyakov
- Skolkovo Territorial Division of the Office of Rospotrebnadzor for the City of Moscow Russia, Moscow, 143026, Russia.,Belgorod State National Research University, Belgorod, 308015, Russia
| | - I A Potemkin
- Mechnikov Research Institute for Vaccines and Sera, Moscow, 105064, Russia.,Russian Medical Academy of Continuous Professional Education, Moscow, 125993, Russia
| | - A A Karlsen
- Mechnikov Research Institute for Vaccines and Sera, Moscow, 105064, Russia.,Russian Medical Academy of Continuous Professional Education, Moscow, 125993, Russia
| | - O V Isaeva
- Mechnikov Research Institute for Vaccines and Sera, Moscow, 105064, Russia.,Russian Medical Academy of Continuous Professional Education, Moscow, 125993, Russia
| | - M A Lopatukhina
- Mechnikov Research Institute for Vaccines and Sera, Moscow, 105064, Russia
| | - E V Mullin
- Mechnikov Research Institute for Vaccines and Sera, Moscow, 105064, Russia
| | - O S Slukinova
- Mechnikov Research Institute for Vaccines and Sera, Moscow, 105064, Russia
| | - E Y Malinnikova
- Mechnikov Research Institute for Vaccines and Sera, Moscow, 105064, Russia.,Russian Medical Academy of Continuous Professional Education, Moscow, 125993, Russia
| | - E V Shibrik
- Department of Health and Social Protection of the Population of Belgorod Region, Belgorod, 308005, Russia
| | - E E Oglezneva
- Belgorod State National Research University, Belgorod, 308015, Russia.,Belgorod Regional Department of Rospotrebnadzor, Belgorod, 308023, Russia
| | - M I Mikhailov
- Mechnikov Research Institute for Vaccines and Sera, Moscow, 105064, Russia.,Russian Medical Academy of Continuous Professional Education, Moscow, 125993, Russia
| |
Collapse
|
13
|
Alatortseva GI, Sidorov AV, Nesterenko LN, Luhverchik LN, Milovanova AV, Ammur YI, Mikhailov MI, Kyuregyan KK, Zhavoronok SV, Zverev VV. OBTAINING THE RECOMBINANT ORF3 PROTEIN OF HEPATITIS E GENOTYPE 3 AND EVALUATION OF ITS ANTIGENIC PROPERTIES. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2018. [DOI: 10.36233/0372-9311-2018-5-46-53] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Aim. Design аис1 construction of the hepatitis E virus (HEV) genotype 3 full-size ORF3 recombimnt polypeptide. Materials and methods. Escherichia coli strains, ptasmid vectors, serologiral and biological amples, molecular biological, bioinformatic, biotechnological, biochemical and serological methods.Results. RNA was isolated from pig fecal extracts collected on Belgorod farms and was used in RT-PCR to obtain the fragment of the orf3 gene of the hepatitis E virus genotype 3. Using A/T-cloning a recombinant plasmid was obtained with insertion of a DNA fragment (230 bp) encoding the N-terminal region of the ORF3 protein. The primary structure of the missing C-terminal region of the ORF3 VGE of the genotype 3 was calculated by bioinformatics methods. Codon optimization of the sequence for biosynthesis in E.coli cells was performed. For constructing the recombinant plasmid a chemically synthesized DNA fragment encoding the fulllength ORF3 protein had been used. E.coli strain producing full-size recombinant protein ORF3 fused to E.coli beta-galactosidase was developed. Recombinant protein ORF3 had been isolated from the inclusion bodies of the E.coli biomass and purified by size exclusion chromatography. Antigenic specificity of recombinant polypeptide had been confirmed in immunochemical reactions (ELISA, Western blot) with sera from patients with hepatitis E and control groups of patients. Conclusion. HEV genotype 3 ORF3 recombinant antigen had been designed, and itfs applicability in diagnostic tests had been experimentally confirmed.
Collapse
Affiliation(s)
| | | | | | | | | | - Yu. I. Ammur
- Mechnikov Research Institute of Vaccines and Sera
| | - M. I. Mikhailov
- Mechnikov Research Institute of Vaccines and Sera, Russian Medical Academy of Postgraduate Education
| | - K. K. Kyuregyan
- Mechnikov Research Institute of Vaccines and Sera, Russian Medical Academy of Postgraduate Education
| | | | - V. V. Zverev
- Mechnikov Research Institute of Vaccines and Sera
| |
Collapse
|
14
|
Alatortseva GI, Sidorov AV, Nesterenko LN, Luhverchik LN, Zhukina MV, Amiantova II, Milovanova AV, Vorobev DS, Ammur YI, Mikhailov MI, Kyuregyan KK, Kichatova VS, Potemkin IA, Isaeva OV, Malinnikova EY, Karlsen AA, Blinov VM, Nurmatov ZS, Nurmatov AZ, Kasymov OT, Zhavoronok SV, Zverev VV. DESIGN OF HEPATITIS E VIRUS GENOTYPE 1 RECOMBINANT ORF3 PROTEIN BY CODON OPTIMIZATION METHOD. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2017. [DOI: 10.36233/0372-9311-2017-6-63-72] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Aim. The development of the hepatitis E virus (HEV) genotype 1 full-size ORF3 recombinant polypeptide. Materials and methods. Escherichia coli strains, plasmid vectors, serological and clinical samples, ELISA reagent kits, molecular biological, bioinformatic, biotechnological, biochemical and serological methods. Results. HEV genotype 1 RNA had been isolated from clinical samples collected in Kyrgyzstan. DNA copy of subgenomic virus RNA had been cloned and used for further development of E.coli strains producing full-size recombinant protein ORF3 fused to E.coli beta-galactosidase. Codons optimization method was used in aim to increase expression level of recombinant protein. Recombinant protein ORF3 had been isolated from the inclusion bodies of the E.coli biomass and purified by size exclusion chromatography. Antigenic specificity of recombinant polypeptide had been confirmed by enzyme-linked immunosorbent assay and Western blotting with the specific sera. Conclusion. HEVgenotype 1 ORF3 recombinant antigen had been designed, and it’s applicability in diagnostic tests had been experimentally confirmed.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | - Yu. I. Ammur
- Mechnikov Research Institute of Vaccines and Sera
| | - M. I. Mikhailov
- Mechnikov Research Institute of Vaccines and Sera, Russian Medical Academy of Continuous Professional Education
| | - K. K. Kyuregyan
- Mechnikov Research Institute of Vaccines and Sera, Russian Medical Academy of Continuous Professional Education
| | - V. S. Kichatova
- Mechnikov Research Institute of Vaccines and Sera, Russian Medical Academy of Continuous Professional Education
| | - I. A. Potemkin
- Mechnikov Research Institute of Vaccines and Sera, Russian Medical Academy of Continuous Professional Education
| | - O. V. Isaeva
- Mechnikov Research Institute of Vaccines and Sera, Russian Medical Academy of Continuous Professional Education
| | - E. Yu. Malinnikova
- Mechnikov Research Institute of Vaccines and Sera, Russian Medical Academy of Continuous Professional Education
| | - A. A. Karlsen
- Mechnikov Research Institute of Vaccines and Sera, Russian Medical Academy of Continuous Professional Education
| | - V. M. Blinov
- Mechnikov Research Institute of Vaccines and Sera
| | | | | | - O. T. Kasymov
- Scientific Production Association «Preventive Medicine»
| | | | - V. V. Zverev
- Mechnikov Research Institute of Vaccines and Sera
| |
Collapse
|
15
|
Alatortseva GI, Sidorov AV, Nesterenko LN, Luhverchik LN, Dotsenko VV, Amiantova II, Kabargina VY, Milovanova AV, Vorobev DS, Ammur YI, Blinov VM, Nurmatov AZ, Nurmatov ZS, Baiyzbekova DA, Kasymov OT, Kyuregyan KK, Mikhailov MI, Zhavoronok SV, Zverev VV. DESIGN OF HEPATITIS E VIRUS GENOTYPE 1 RECOMBINANT CAPSID PROTEIN: CLONING, EXPRESSION, PURIFICATION, EVALUATION OF THE ANTIGENIC PROPERTIES. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2017. [DOI: 10.36233/0372-9311-2017-6-72-80] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Aim. The development of the hepatitis E virus (HEV) genotype 1 recombinant capsid protein. Materials and methods. Escherichia coli strains, plasmid vectors, serological and clinical samples, ELISA reagent kits, molecular biological, bioinformatic, biotechnological, biochemical and serological methods. Results. Using HEV genotype 1 DNA copy of subgenomic virus RNA we made E.coli strains producing recombinabt capsid protein, containing C-terminal fragment of ORF2 protein fused to E.coli beta-galactosidase. Recombinant protein ORF2 had been isolated from the inclusion bodies of the E.coli biomass and purified by size exclusion chromatography. By Western blotting it had been shown specific interaction of the recombinant polypeptide with anti-HEV IgG from pool of positive sera. Antigenic specificity of the recombinant polypeptide had been confirmed by enzyme-linked immunosorbent assay with sera of hepatitis E patients and reference groups: healthy donors, patients with hepatitis А, В, C, infectious mononucleosis and cytomegalovirus infection, HIV-infected patients. Conclusion. HEV genotype 1 ORF2 recombinant antigen had been developed, and its possible use in diagnostic tests had been experimentally shown.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | - Yu. I. Ammur
- Mechnikov Research Institute of Vaccines and Sera
| | - V. M. Blinov
- Mechnikov Research Institute of Vaccines and Sera
| | | | | | | | - O. T. Kasymov
- Scientific Production Association «Preventive Medicine»
| | - K. K. Kyuregyan
- Mechnikov Research Institute of Vaccines and Sera, Russian Medical Academy of Continuous Professional Education
| | - M. I. Mikhailov
- Mechnikov Research Institute of Vaccines and Sera, Russian Medical Academy of Continuous Professional Education
| | | | - V. V. Zverev
- Mechnikov Research Institute of Vaccines and Sera
| |
Collapse
|
16
|
Gulyaev SA, Potemkin IA, Kichatova VS, Karlsen AA, Isaeva OV, Guiyaeva TV, Vannus MA, Gordeichuk IV, Kyuregyan KK, Mikhailov MI. MODELLING OF HEPATITIS E IN MINI-PIGS. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2017. [DOI: 10.36233/0372-9311-2017-4-48-54] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Aim. Experimental reproduction of HEV-infection in mini-pigs and comparative analysis of virological and immunological characteristics of experimental infection. Materials and methods. Wiesenauer minipigs (2 females and 4 males, age 50 - 60 days, weight 5-10 kg) were infected by HEV genotype 3 strain isolated from swine feces in Belgorod region in 2013. The virus was administered as a 10% clarified feces extract (800 pi). Blood (weekly) and feces (daily) were sampled from the animals for 49 days. Anti-HEV IgG were determined in sera samples using DS- ElA-ANTI-HEV-G (Diagnostic Systems) system, HEV RNA in samples of feces extracts and blood sera - RT-PCR. Results. Wiesenauer minipigs were sensitive to HEV genotype 3 infection, infection developed in all the animals after administration of the virus, that was accompanied by the presence of HEV RNA in feces for 2 weeks and seroconversion by anti-HEV. Comparative analysis of virological characteristics of experimental H EV-infection in mini- and standard pigs has shown, that the duration of the infection in mini-pigs is shorter, and seroconversion by anti-HEV occurs earlier. Conclusion. Sensitivity to HEV genotype 3 and lower weight make mini-pigs a comfortable alternative to standard swine and primates for modelling HEV infection in vivo.
Collapse
Affiliation(s)
- S. A. Gulyaev
- Chumakov Institute of Poliomyelitis and Viral Encephalitis
| | - I. A. Potemkin
- Russian Medical Academy of Continuous Professional Education, Mechnikov Research Institute of Vaccines and Sera
| | - V. S. Kichatova
- Russian Medical Academy of Continuous Professional Education, Mechnikov Research Institute of Vaccines and Sera
| | - A. A. Karlsen
- Russian Medical Academy of Continuous Professional Education, Mechnikov Research Institute of Vaccines and Sera
| | - O. V. Isaeva
- Russian Medical Academy of Continuous Professional Education, Mechnikov Research Institute of Vaccines and Sera
| | - T. V. Guiyaeva
- Chumakov Institute of Poliomyelitis and Viral Encephalitis
| | - M. A. Vannus
- Chumakov Institute of Poliomyelitis and Viral Encephalitis
| | | | - K. K. Kyuregyan
- Russian Medical Academy of Continuous Professional Education, Mechnikov Research Institute of Vaccines and Sera
| | - M. I. Mikhailov
- Russian Medical Academy of Continuous Professional Education, Mechnikov Research Institute of Vaccines and Sera
| |
Collapse
|
17
|
Morozov IA, Ilchenko LY, Kyuregyan KK, Karlsen AA, Fediukina ES, Fedorov IG, Petrenko NV. THE FIRST TWO CASES OF CHRONIC HEPATITIS ASSOCIATED WITH TORQUE TENO MIDI VIRUS (TTMDV), GENUS GAMMATORQUEVIRUS. ACTA ACUST UNITED AC 2017. [DOI: 10.20514/2226-6704-2017-7-1-71-77] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
|
18
|
AlSalih ND, Sychev DA, Potemkin IA, Kyuregyan KK, Mikhailov MI. The prevalence of serological markers of viral hepatitis among labor migrants arriving in the Russian Federation. ACTA ACUST UNITED AC 2017. [DOI: 10.22625/2072-6732-2017-9-2-80-85] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
19
|
Korzaia LI, Keburia VV, Dogadov DI, Lapin BA, Kyuregyan KK, Mikhailov MI. Markers of hepatitis E among the population of the Greater Sochi and in monkeys of the Adler primate center. Vopr Virusol 2016; 61:176-180. [PMID: 36494966 DOI: 10.18821/0507-4088-2016-61-4-176-180] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2020] [Indexed: 12/13/2022]
Abstract
Serum from humans (n = 646) and monkeys (n = 1867) collected during the period 1999-2013 was tested by enzyme immunoassay. Anti-HEV IgG was detected significantly more frequently (P ≥ 0.001) in rhesus macaques (Macaca mulatta) - 45.1 ± 1.6% (n = 1001) than in cynomolgus macaques (M. fascicularis) 16.2 ± 1.8% (n = 426). Single seropositive individuals were found among M. nemestrina - 4.0±2.8% (n = 50). Anti-HEV was not detected in the sera of green monkeys (Chlorocebus aethiops) - n = 162, Papio hamadryas (n = 124), and Papio anubis - n = 104. The presence of the anti-HEV IgM indicating the cases of fresh infection in Macaca mulatta - 2.1 ± 0.5% (n = 717) and M. fascicularis - 3.5 ± 1.3% (n = 266) is of great significance. The overall frequency of detection of the anti-HEV IgG among the staff of the Adler Primate Center - 6.8 ± 2.3% (n = 118) was significantly lower (P ≤ 0.001) than among the population of the Greater Sochi - 15.9% ± 1.6 (n = 528). It is important that only in patients of medical institutions (clinic, hospital, cancer center), anti-HEV IgM were detected (2.7-11.8%) along with anti-HEV IgG (15-23.5%), thereby indicating the presence of acute cases of HEV infection among this population. HEV RNA was not detected in the serum of anti-HEV IgM-positive people and monkeys. Seroepidemiological data do not confirm the assumption on the ability of seropositive monkeys of Macaca genus to be a natural reservoir of HEV infection for humans.
Collapse
Affiliation(s)
| | | | | | - B A Lapin
- Research Institute of Medical Primatology
| | - K K Kyuregyan
- Chumakov Institute of Poliomyelitis and Viral Encephalitides
| | - M I Mikhailov
- Chumakov Institute of Poliomyelitis and Viral Encephalitides
| |
Collapse
|
20
|
Abstract
Aim. Description of the first documented case of imported hepatitis E, associated with genotype 4 of HEV and introduced from southern France. Materials and methods. Clinical, epidemiologic and laboratory analysis of the imported case of disease of hepatitis E was carried out. Phylogenetic analysis of nucleotide sequences of HEV isolate, taken from the patient, was carried out. Results. Epidemiologic analysis allowed to assume imported character of the detected case of HEV-infection. Comparative analysis of nucleotide sequences of regions of the open reading frame 2 (300 nt) and open reading frame 1 (721 nt) of HEV genome, isolated from the patient, showed identity of this isolate with variants of genotype 4 HEV, isolated in France in 2009 - 2011 from patients with autochthonous hepatitis E. Conclusion. The results obtained confirm the case of import into Russia of genotype 4 HEV from south-eastern France (Corsica), where spread of this virus genotype is observed in recent years.
Collapse
Affiliation(s)
| | - E. Yu. Malinnikova
- Chumakov Institute of Poliomyelitis and Viral Encephalites; Russian Medical Academy of Post-Graduate Education
| | | | - O. V. Isaeva
- Chumakov Institute of Poliomyelitis and Viral Encephalites
| |
Collapse
|
21
|
Mikhailov ML, Malinnikova EY, Kyuregyan KK, Isaeva OV. [A CASE OF IMPORT OF GENOTYPE 4 HEPATITIS E VIRUS INTO RUSSIA]. Zh Mikrobiol Epidemiol Immunobiol 2016:64-69. [PMID: 30695455] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
AIM Description of the first documented case of imported hepatitis E, associated with geno- type 4 of HEV and introduced from southern France. MATERIALS AND METHODS Clinical, epidemio- logic and laboratory analysis of the imported case of disease of hepatitis E was carried out. Phylogenetic analysis of nucleotide sequences of HEV isolate, taken from the patient, was carried out. RESULTS Epidemiologic analysis allowed to assume imported character of the detected case of HEV-infection. Comparative analysis ofnucleotide sequences of regions ofthe open reading frame 2 (300 nt) and open reading frame 1 (721 nt) of HEV genome, isolated from the patient, showed identity of this isolate with variants of genotype 4 HEV, isolated in France in 2009 - 2011 from patients with autochthonous hepatitis E. CONCLUSION The results obtained confirm the case of import into Russia of genotype 4 HEV from south-eastern France (Corsica), where spread of this virus genotype is observed in recent years.
Collapse
|
22
|
Kyuregyan KK, Poleshchuk VF, Gordeichuk IV, Gulyaeva TV, Isaeva OV, Morozov IA, Mikhailov MI. Simulation of Viral Hepatitis E in Marmosets. Bull Exp Biol Med 2016; 160:368-71. [PMID: 26750931 DOI: 10.1007/s10517-016-3173-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2014] [Indexed: 11/25/2022]
Abstract
We developed a model of hepatitis E virus infection in common marmosets (Callithrix jacchus) and determined optimal route of infection, duration, clinical and virological characteristics of infection in laboratory animals. Using this model, we demonstrated that replication of hepatitis E virus primarily occurs in the liver, while virus replication presumed to take place in the intestine was not confirmed in this experiment.
Collapse
Affiliation(s)
- K K Kyuregyan
- M. P. Chumakov Institute of Poliomyelitis and Viral Encephalitides, Russian Academy of Medical Sciences, Moscow, Russia.
| | - V F Poleshchuk
- M. P. Chumakov Institute of Poliomyelitis and Viral Encephalitides, Russian Academy of Medical Sciences, Moscow, Russia
| | - I V Gordeichuk
- M. P. Chumakov Institute of Poliomyelitis and Viral Encephalitides, Russian Academy of Medical Sciences, Moscow, Russia
| | - T V Gulyaeva
- M. P. Chumakov Institute of Poliomyelitis and Viral Encephalitides, Russian Academy of Medical Sciences, Moscow, Russia
| | - O V Isaeva
- M. P. Chumakov Institute of Poliomyelitis and Viral Encephalitides, Russian Academy of Medical Sciences, Moscow, Russia
| | - I A Morozov
- M. P. Chumakov Institute of Poliomyelitis and Viral Encephalitides, Russian Academy of Medical Sciences, Moscow, Russia
| | - M I Mikhailov
- M. P. Chumakov Institute of Poliomyelitis and Viral Encephalitides, Russian Academy of Medical Sciences, Moscow, Russia
| |
Collapse
|
23
|
Diarrassouba A, Potemkin IA, Lopatukhina MA, Isaeva OV, Kyuregyan KK, Mikhailov MI. [The standardization of diagnostic of hepatitis E.]. Klin Lab Diagn 2016; 61:299-303. [PMID: 31529911 DOI: 10.18821/0869-2084-2016-5-299-303] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2015] [Accepted: 12/15/2015] [Indexed: 06/10/2023]
Abstract
The study was carried out to develop approaches to standardization of laboratory diagnostic of hepatitis E. The three stages of standardization are establishment of analytical sensitivity of molecular test for detection of RNA of virus of hepatitis E; establishment of analytical sensitivity in International Units of enzyme-linked immunosorbent assay testing widely applied in Russia for detection of anti-virus of hepatitis E; And development of national reference material - standard anti-virus of hepatitis E IgG validated relatively to International standard. The results of study permitted to develop tools for standardizing of laboratory diagnostic of hepatitis E and epidemiological control of the given function - molecular test for detecting RNA of virus of hepatitis E with sensitivity within range of 1250250 IU/ml, data concerning analytical sensitivity of commercial enzyme-linked immunosorbent assay testing for detecting anti-virus of hepatitis E (0.25 IU/ml) and national standard of anti-virus of hepatitis E with concentration of 5 IU/ml.
Collapse
Affiliation(s)
- A Diarrassouba
- The M.P. Chumakov institute of poliomyelitis and viral encephalitis, 142784, Moscow, Russia
| | - I A Potemkin
- The M.P. Chumakov institute of poliomyelitis and viral encephalitis, 142784, Moscow, Russia
| | - M A Lopatukhina
- The M.P. Chumakov institute of poliomyelitis and viral encephalitis, 142784, Moscow, Russia
| | - O V Isaeva
- The M.P. Chumakov institute of poliomyelitis and viral encephalitis, 142784, Moscow, Russia
| | - K K Kyuregyan
- The M.P. Chumakov institute of poliomyelitis and viral encephalitis, 142784, Moscow, Russia
| | - M I Mikhailov
- The M.P. Chumakov institute of poliomyelitis and viral encephalitis, 142784, Moscow, Russia
| |
Collapse
|
24
|
Potemkin IA, Lopatukhina MA, Gadzhieva OA, Prokhorova EL, Diyarrassuba A, Isaeva OA, Kozhanova TV, Ivanova OE, Silenova OV, Setdikova NK, Kyuregyan KK, Mikhailov MI. [Prevalence of hepatitis E markers in children]. Zh Mikrobiol Epidemiol Immunobiol 2015:38-46. [PMID: 26016342] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
AIM Frequency of detection determination for past and current hepatitis E virus (HEV) infection markers in children with immune suppression, as well as children with normal immune status. MATERIALS AND METHODS The presence of HEV markers (anti-HEV IgG and IgM, HEV RNA) was studied in 609 sera samples of children with neurologic pathologies, 87 samples--from children with immune deficiencies, as well as 3122 samples from conditionally healthy children of 6 regions of Russia. The children were divided into 5 age groups. Anti-HEV IgG and IgM determination was carried out in EIA, HEV RNA--by RT-PCR. RESULTS The frequency of detection of anamnestic anti-HEV IgG turned out to be significantly higher among immune-compromised. children compared with healthy children (5.7% against 1.4%, p < 0.05). Anti-HEV IgM, that testify to current or recent infection, were also detected significantly more frequently among children with immune-suppression (1.1-1.6%) compared with healthy children (0.25%, p < 0.05). HEV RNA was detected in 1 child with the absence of anti-HEV IgM and IgG. Nucleotide sequence analysis of HEV confirmed membership of this isolate in genotype 3, that is prevalent in non-endemic territories. CONCLUSION The data obtained have demonstrated, that HEV-infection is prevalent among children in Russia and its course is, probably, asymptomatic in most cases. Immune suppression is a factor of increased risk of infection of children with HEV.
Collapse
|
25
|
Morozov IA, Zwerkova EA, Kyuregyan KK, Karlsen AA, Isaeva OV, Ilchenko LY, Fedorov IG, Kozhanova TV, Gordeychuk IV, Petrenko NV, Mikhailov MI. [GENUS ANELLOVIRIDAE VIRUSES IN CHRONIC LIVER DISEASE]. Eksp Klin Gastroenterol 2015:4-11. [PMID: 26817116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
AIM Viruses from genus Anelloviridae (TTV, TTMDV and TTMV) are small DNA viruses that are widespread in human popu- lation. Data on tissue tropism, cell localization and morphometry of anelloviruses are scarce. The purpose of this study was to determine the prevalence of TTV, TTMDV and TTMV in persons with liver disease and in healthy individuals, as well as electron-microscopic verification of Anelloviridae species. METHODS Detection of anelloviral DNA was performed in serum samples from 203 patients with liver diseases of various etiology and 115 voluntary blood donors using PCR with primers allowing to differentiate TTV, TTMDV TTMV based on the length of amplified fragment. Histopathological and electron microscopic studies were performed for liver biopsy specimens from 203 patients with liver disease. RESULTS High prevalence (70-90%) of all three anelloviruses in healthy individuals and patients with liver disease was demonstrated, with high frequency of triple TTV, TTMDV and TTMV infection (52.2-55.7%). Electron-microscopic study of liver biopsy specimens from TTMDV monoinfected patients gave a submicroscopic image of TTMDV virions with diameter 35.86 ± 2.04 nm. Electron microscopic studies confirmed the nature of liver damage in TTMDV monoinfection: accumulation of virus in the hepatocytes, significant cyropathy with enlightenment matrix of the cytoplasm and reduction of intracellula organelles involved in protein synthesis, portal and perivascular perisinusoidal fibrosis. TTV, TTMDV and TTMV virions were dentified in hepatocytes, confirming these viruses to be hepatotropic. CONCLUSION Our results demonstrate that anelloviruses are lymphotropic viruses, individual genotypes of those might be hepatotropic and pathogenic to liver.
Collapse
|
26
|
Kozhanova TV, Ilchenko LY, Lopatuchina MA, Saryglar AA, Saryg-Chaa ON, Sonam-Baiyr YD, Mongusch MK, Kyuregyan KK, Mikhailov MI. [FAMILIAL CLUSTERS OF HEPATITIS DELTA IN ENDEMIC REGION (REPUBLIC TYVA)]. Eksp Klin Gastroenterol 2015:15-22. [PMID: 27214982] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
AIM Clinical and virological characteristic of hepatitis delta familial clusters in region of Russia that is endemic for this infection (Republic Tuva). MATERIALS AND METHODS Total 383 patients with HBV/HDV coinfection and their family members (3 generations) were followed. Serum samples for HDV and HBV markers testing were available for 42 patients from 18 families. HBsAg, anti-HBc, HBeAg, anti-HBe and anti-HDV were tested using commercial ELISA tests; HDV RNA and HBV DNA were tested using in house nested PCR tests. RESULTS 30 family (63 people) clusters were identified, in which close living persons have been infected with HDV and HBV. The biological material for determining of HDV and HBV markers has been available from 18 families (42 people belonging to 1-3 generations (parents and children, husband and wife, brother and sister). The mean age was 35 ± 14 years (10-58 years). Chronic hepatitis (CH) was in 30 (71.4%) patients, liver cirrhosis (LC)--in 10 (23.8%) and HCC was developed in 2 (4.8%) person on the background of long infections. The incidence of HBeAg was 14.3% (6/42), HBV DNA--19% (8/42); HDV RNA--35.7% (15/42). In 2 cases (mother) replication markers of both viruses were found, it contributed to the increased risk of infection in children. So HDV RNA was detected in the blood serum of their daughters (15 and 17), that does not exclude the possibility of vertical transmission. An illustration describes four families. CONCLUSION The epidemic process of delta infection in the Republic of Tyva is characterized by intrafamilial infection of HBV and HDV.
Collapse
|
27
|
Juman Awadh A, Kyuregyan KK, Isaeva OV, Mikhailov MI. Comparative characterization of two tests for measurement of hepatitis B virus DNA in the blood serum and plasma, based on the use of two different detection methods. Bull Exp Biol Med 2009; 146:246-9. [PMID: 19145329 DOI: 10.1007/s10517-008-0260-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Two tests for measurements of hepatitis B virus DNA in human serum and plasma, VERSANT HBV 3.0 (based on the use of branched DNA chains) and Biotitre-B (a real-time PCR variant), were compared. Serum specimens from patients (n=56) with documented viral hepatitis were tested. For specimens with DNA values in the linear range in both tests the correlations were evaluated by Pearson's method. The sensitivity of the two tests, and reproducibility of the results of HBV DNA measurements were evaluated using a panel of recombinant virus DNA dilutions with a step of 1 lg HBV DNA copies per ml (from 7 to 3 lg). Three measurements for each concentration of the reference sample were carried out in each test. Clinical specificity of the two tests was evaluated by the analysis of HBV-negative serum samples, collected from donors not reactive by HBsAg and anti-HBc (n=60). Of 56 samples with documented infection, the results of testing by VERSANT HBV 3.0 and Biotitre-B did not agree in 4 (7.1%) samples. Pearson's correlation coefficient of for results obtained in VERSANT HBV 3.0 and Biotitre-B in linear range for both tests was 0.712. Evaluation of reproducibility of the tests using a panel of recombinant HBV DNA showed higher reproducibility of VERSANT HBV 3.0 test with coefficient of variations from 0.79 to 2.79% vs. 2.39-10.69% for Biotitre-B reference test. All 60 serum samples from donors areactive by HBsAg and anti-HBc were negative by HBV DNA when tested by VERSANT HBV 3.0 and Biotitre-B. Hence, clinical specificity of both tests was 100%. The results indicate high specificity of both tests and good agreement of their results, the reproducibility of VERSANT HBV 3.0 test being higher.
Collapse
Affiliation(s)
- A Juman Awadh
- Peoples' Friendship University of Russia; M. P. Chumakov Institute of Poliomyelitis and Viruses Encephalitis, Russian Academy of Medical Sciences, Moscow, Russia
| | | | | | | |
Collapse
|